My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
Post reference ranges alongside numbers when you share them. Units differ by country — glucose and lipids especially — and half the confusion in these threads is unit mismatch rather than disagreement.
What I am after is how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning.
Tell me what I have not thought of.
Taking the question as asked, rather than the general version of it. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
SarahChen_PharmD said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
SarahChen_PharmD has the substance of this right. The condition it depends on is worth stating. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMikeKY_noInsulin said:My prescriber ordered three tests and this board recommends about twenty, and I would like to know which of those two lists is right.
Same position here, arrived at the long way round. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
Adding the clinical framing, because it changes how the question reads.
PSA: get baseline labs BEFORE starting baseline bloodwork therapy. You need a "before" picture to measure progress. My recommended pre-treatment panel:
Total cost at Quest without insurance: ~$200. Worth every penny for the data.